With this fresh capital, the Bengaluru-based company aims to accelerate its AI-driven product development and expand its global market presence.

Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2024 investor letter. A copy of the ...

Reshma Kewalramani; President, Chief Executive Officer, Director; Vertex Pharmaceuticals Inc Stuart Arbuckle; Chief Operating Officer, Executive Vice President; Vertex Pharmaceuticals Inc Charles ...

Q4 2024 Earnings Call Transcript February 10, 2025 Vertex Pharmaceuticals Incorporated misses on earnings expectations. Reported EPS is $3.98 EPS, expectations were $4.02. Operator: Good day, and ...

The ASX retreated from earlier gains and closed 0.25% lower on Tuesday, following a late-day tumble in pharma giant CSL ...

ASX rises with Nvidia and gold's record high, Trump’s tariffs hit, Albanese talks to Trump, Musk’s OpenAI bid blocked.

Near-term gold producer Vertex Minerals (ASX:VTX)has kicked off commissioning ... a world-leading expert in niobium ore ...

Chesley "Sully" Sullenberger, known for the heroic landing of US Airways Flight 1549 on the Hudson River, weighed in on the ...

Rather than combat said pain at the brain, it functions at the peripheral site of pain. Journavx’s manufacturer Vertex Pharmaceuticals says this lessens the addictive potential. “Taking opioids every ...

Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.

Sana Biotechnology and Vertex Pharmaceuticals represent the region’s leadership in cell and gene therapy, while Inventprise reflects Washington’s roots in global health and vaccines.